Table 6.
Change from baseline mean Ashworth scores for upper and/or lower limb in Study 1.
| All Patients (N = 109) |
Placebo (n = 36) |
OnabotA 240 U (n = 36) |
OnabotA 360 U (n = 37) |
p-Values OnabotA 240 U vs. Placebo |
p-Values OnaboA 360 U vs. Placebo |
|---|---|---|---|---|---|
| Baseline | 3.0 | 2.9 | 2.7 | 0.497 | 0.123 |
| Week 1 | −0.4 | −0.7 * | −0.9 * | 0.007 | 0.001 |
| Week 3 | −0.5 | −0.9 * | −0.9 * | 0.003 | 0.013 |
| Week 6 | −0.2 | −0.8 * | −0.8 * | <0.001 | 0.003 |
| Week 12 | 0.0 | −0.3 | −0.3 | 0.061 | 0.064 |
| Week 13 | −0.3 | −0.7 * | −0.7 * | 0.017 | 0.029 |
| Week 15 | −0.3 | −0.7 * | −0.7 | 0.031 | 0.055 |
| Week 18 | −0.1 | −0.7 * | −0.6 * | 0.001 | 0.013 |
* p-value ≤ 0.05 for onabotA vs. placebo.